Regulating Human Embryonic Stem Cell in China

A Comparative Study on Human Embryonic Stem Cell’s Patentability and Morality in US and EU

Häftad, Engelska, 2018

AvLi Jiang

1 389 kr

Beställningsvara. Skickas inom 10-15 vardagar. Fri frakt för medlemmar vid köp för minst 249 kr.

Finns i fler format (1)

Inbunden

1 279 kr

Skickas inom 10-15 vardagar

The general scope of the book is the patentability and morality of human embryonic stem cell research in US, EU and China. The book observes fraudsters operate unsafe human embryonic stem cell therapies and officialdom turns a blind eye to the immoral human embryonic stem cell research in China.

Produktinformation

Utgivningsdatum2018-06-12
Mått155 x 235 x 13 mm
Vikt341 g
FormatHäftad
SpråkEngelska
Antal sidor200
FörlagSpringer Verlag, Singapore
ISBN9789811095283

Tillhör följande kategorier

Li Jiang is currently a lecturer in Kenneth Wang School of Law, Soochow University. Born in China, Li Jiang was educated at Shandong University, China and graduated with a Bachelors degree in Biotechnology. Li Jiang gained her PhD degree at Bangor University Law School in 2014. Jiang’s research looks at the scope of patentability in respect of the application of the moral exclusion to human embryonic stem cell research through a comparative analysis of the diverging interpretations which have emerged in the regulations of US, EU and China. Many pieces of Jiang’s work have been published by leading international journals in Australia and the United States.

Values of Human Embryonic Stem Cell Research, the phenomenon of “Stem Cell Tourism” and Inadequate regulation of Human Embryonic Stem Cell in China.- The Moral Maze In Human Embryonic Stem Cell Research: the moral status of human embryo and the moral source of human embryonic stem cell.- China: inconsistent moral standards of human embryonic stem cell research between patent law and practical application.- The United States: Inconsistent policies on federal funding control of human embryonic stem cell research.- The European Union: Inconsistent interpretations of moral provisions in Patent Convention addressing human embryonic stem cell research.- A proposal for controlling human embryonic stem cell research in China: regulate research itself in a reconciled human embryonic stem cell regulation at the international regime.